跳至主要内容
临床试验/EUCTR2013-002807-32-DK
EUCTR2013-002807-32-DK进行中(未招募)不适用

Antibiotic treatment for patients with infectious endocarditis: continuous infusion, guided by therapeutic drug monitoring, versus intermittent infusions (the CONTENT study). - CONTENT

Aarhus University Hospital, Department of Cardiology0 个研究点目标入组 40 人开始时间: 2013年9月3日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Verified infectious endocarditis, with bacteria in the blood, susceptible for either Benzylpenicillin or Diclocil.
  • 2. Less than 96 hours since the onset of intra venous antibiotic treatment.
  • 3. Use of contraception (for fertile women)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • 1. Negative blood cultures.
  • 2. More than 96 hours since the onset of intra venous antibiotic treatment.
  • 3. Planned valve surgery.
  • 4. Planned extraction of a pace maker.
  • 5. Allergy to Benzylpenicillin or Diclocil.
  • 6. Unability to understand information about the study and to give informed consent.
  • 7. Age under 18.
  • 8. Preagnancy.
  • 9. Breastfeeding.

研究者

发起方
Aarhus University Hospital, Department of Cardiology

相似试验

进行中(未招募)
不适用
Antibiotic treatment in patients hospitalized with an acute exacerbation in chronic obstructive pulmonary disease. Effect of one day of antibiotic treatment compared t0 6 days of antibiotic treatment in patients who are clinically stable 24 hours after hospitalization. A prospective, randomized, double-blind trial - TaexaCOPAcute exacerbation of chronic ostructive pulmonary disease in hospitalized patients. All patients receive standard of care, and 1 day of intravenous antibiotics. In addition patients are randomized to treatment with Vibradox 200 mg QD in 5 days or matching placebo. The primary outcome variable is 6 minutes walking distance at day 14 after hospitalization.MedDRA version: 9.1Level: LLTClassification code 10056971Term: Infective exacerbation of chronic obstructive airways disease
EUCTR2007-007275-16-DKDepartment of Infetious Diseases, Odense University Hospital
招募中
4 期
Antibiotic therapy vs. placebo in the treatment of acute uncomplicated appendicitis: a prospective randomized double-blind placebo-controlled trial - APPAC III
2025-520761-44-00Turku University Hospital72
进行中(未招募)
1 期
Comparison of the effect of shortened versus standard antibiotic treatment in patients infected with Gram negative bacteria with a urinary tract source of infectioGram-negative bacteremiaMedDRA version: 20.1Level: LLTClassification code 10054228Term: Gram-negative bacteremiaSystem Organ Class: 10021881 - Infections and infestations
EUCTR2019-003282-17-DKThomas Benfield380
进行中(未招募)
1 期
Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study
CTIS2024-514900-16-00Hvidovre Hospital380
进行中(未招募)
1 期
Treatment of viral infections after stem cell Transplantation with specific immune cellschemo-refactory AdV, CMV and EBV infections after allogeneic stem cell transplantation
EUCTR2018-000853-29-ESKlinikum der Universität München149